Scarica l'app Stockscreener
94.00
2.04%
1.88
Dopo l'orario di chiusura:
94.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$92.12
Aprire:
$92.87
Volume 24 ore:
1.46M
Relative Volume:
1.10
Capitalizzazione di mercato:
$10.91B
Reddito:
$2.77B
Utile/perdita netta:
$286.61M
Rapporto P/E:
40.00
EPS:
2.35
Flusso di cassa netto:
$524.11M
1 W Prestazione:
+2.55%
1M Prestazione:
+10.23%
6M Prestazione:
+0.27%
1 anno Prestazione:
-21.78%
Intervallo 1D:
$92.47
$95.35
Intervallo di 1 settimana:
$88.06
$95.35
Portata 52W:
$81.36
$129.50
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Confronta RVTY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
94.00 | 10.58B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Why analysts remain bullish on Revvity Inc. stockWeekly Investment Report & Growth Focused Stock Reports - newser.com
Guggenheim Initiates Coverage of Revvity (RVTY) with Neutral Recommendation - Nasdaq
Guggenheim Initiates Coverage on Revvity (RVTY) with Neutral Rat - GuruFocus
Does Revvity’s (RVTY) Sanofi Partnership and Expanded T1D Diagnostics Shift Its Long-Term Growth Outlook? - Yahoo Finance
Guggenheim initiates coverage on Revvity stock with Neutral rating - Investing.com
Here's What to Expect From Revvity's Next Earnings Report - Yahoo Finance
Applying big data sentiment scoring on Revvity Inc.Portfolio Update Summary & Reliable Entry Point Trade Alerts - newser.com
Ex-Dividend Reminder: Revvity, Dime Community Bancshares and TD SYNNEX - Nasdaq
Research Tools & Consumables Stocks Q2 Teardown: Revvity (NYSE:RVTY) Vs The Rest - Yahoo Finance
Is Revvity Inc. stock undervalued vs historical averagesJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
A major biomanufacturer is cutting over 100 jobs in Mass. - Boston.com
TD Cowen Adjusts Price Target on Revvity to $120 From $126, Maintains Buy Rating - MarketScreener
Revvity Showcases Progress with Purpose in 2025 Impact Report - Business Wire
Revvity Unveils New AI Software Offering To Transform Preclinical Imaging Analysis - Technology Networks
Will Revvity Inc. rebound enough to break evenTrade Analysis Report & Daily Growth Stock Investment Tips - newser.com
Chart based analysis of Revvity Inc. trends2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
How Revvity Inc. (PKN) stock reacts to Fed tightening2025 Trading Volume Trends & Weekly High Return Stock Opportunities - newser.com
Revvity's Moat Rating Downgraded as Portfolio Transformations Weigh on Economic Returns - Morningstar
Revvity Closes Second Massachusetts Site, Increases Layoffs Amid Operational Consolidation - Boston Real Estate Times
Can Revvity Inc. stock withstand economic slowdownJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Leerink Partners Adjusts Revvity Price Target to $120 From $110, Maintains Outperform Rating - MarketScreener
Revvity, Inc. (RVTY) Stock Analysis: Exploring 30% Potential Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Revvity (RVTY): Assessing Valuation Following Sanofi Alliance for Population-Scale Diabetes Diagnostics Expansion - Sahm
Sivik Global Healthcare LLC Purchases Shares of 45,000 Revvity Inc. $RVTY - MarketBeat
Revvity Inc. $RVTY Shares Bought by Triodos Investment Management BV - MarketBeat
Revvity, Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges - Markets Mojo
Major Mass. biomanufacturer closes 2nd site, lays off more workers - The Business Journals
Medpace and Revvity Stocks Trade Down, What You Need To Know - TradingView
Revvity Inc. stock momentum explained2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Using fundamentals and technicals on Revvity Inc.Market Sentiment Summary & Verified Technical Trade Signals - newser.com
How to track smart money flows in Revvity Inc.IPO Watch & Safe Capital Growth Trade Ideas - newser.com
MA biomanufacturer Revvity to close Boston facility, lay off dozens of employees - Yahoo
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes - sharewise.com
Revvity Inc. stock trend outlook and recovery pathFed Meeting & Risk Managed Investment Strategies - newser.com
Will Revvity Inc. see short term momentumJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Best data tools to analyze Revvity Inc. stock2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Is Revvity Inc. stock a top pick for value investorsWeekly Trend Summary & AI Powered Market Trend Analysis - newser.com
Will Revvity Inc. (PKN) stock enhance shareholder valueWeekly Investment Recap & Stock Timing and Entry Methods - newser.com
Will Revvity Inc. stock sustain high P E ratios2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Revvity (RVTY): Evaluating Valuation Potential After Recent Modest Recovery in Share Price - Yahoo Finance
Evercore ISI Group Maintains Revvity (RVTY) Outperform Recommendation - Nasdaq
Evercore ISI Lowers Revvity (NYSE:RVTY) Price Target to $106.00 - MarketBeat
Evercore ISI Adjusts Revvity Price Target to $106 From $108, Maintains Outperform Rating - MarketScreener
Drake & Associates LLC Acquires 12,553 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity to Hold Earnings Call on Monday, October 27, 2025 - PharmiWeb.com
Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout - MedTech Dive
Revvity (RVTY) Is Up 11.9% After Announcing Sanofi Alliance to Expand Diabetes Diagnostics Portfolio - Sahm
What drives Revvity Inc stock priceShort-Term Trading Alerts & These Picks Are Just One Breakout Away - earlytimes.in
Can a trend reversal in Revvity Inc. lead to recoveryChart Signals & Stock Timing and Entry Methods - newser.com
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):